PhDs first, communicators second — accountable scientific execution from hypothesis to publication
Science Habitat is the scientific consulting, medical writing, evidence synthesis, and bioinformatics practice of Ubioquitos Inc., headquartered in London, Ontario, Canada, with specialist scientific delivery operations in India.
Who We Are & Why We Exist
Rigorous science frequently stalls at the communication and analytical verification step rather than in the laboratory. A manuscript with an unfocused narrative or unverified statistical tables faces desk rejection; a grant application without a tight Specific Aims page goes unfunded; a systematic review or HTA dossier with non-reproducible search strings fails appraisal.
Science Habitat was founded to close that gap. Every engagement is scoped, executed, and signed off by named PhD scientists with first- and senior-author publication track records in international peer-reviewed journals. We do not hand projects off to generalist copywriters or unverified automated tools.
Our Mission
Shorten the distance between complex experimental or clinical data and defensible, peer-review-ready scientific communication.
Our Accountability Model
One scientific lead scopes and signs off the deliverable under a documented 6-step QC checklist and mutual NDA.
Corporate & Delivery Footprint
- Legal Corporate Entity
- Ubioquitos Inc. (Incorporated in Canada; operating as Science Habitat)
- Canadian Headquarters (Client Contracting & Scientific Leadership)
- 1554 Trossacks Ave, London, ON N5X 4R8, Canada
Tel: +1 (819) 432-4767 · Email: debasis.sahu@sciencehabitat.com - India Scientific Delivery Centre
- Specialist PhD medical writing, PRISMA screening, and bioinformatics delivery team operating in New Delhi / NCR, India under unified SOPs, role-based access controls, and Canadian leadership sign-off.
- Engagement Models
- Fixed-Scope Milestone Projects & Dedicated Programme Retainers.
Scientific Leadership & Principal Investigators
Debasis (Dev) Sahu, PhD
Dr. Debasis Sahu holds a PhD in Biomedical Sciences (University of Delhi / CSIR–Institute of Genomics and Integrative Biology) and completed postdoctoral and translational research fellowships at the National Institute of Immunology (NII), New York University Grossman School of Medicine, and the Children’s Health Research Institute / Western University (London, Ontario).
Over a 15+ year research career spanning quantitative mass-spectrometry proteomics (iTRAQ, LC-MS/MS), targeted metabolomics, immunopharmacology, and translational biomarker discovery, Dr. Sahu has authored 27+ peer-reviewed publications and book chapters with over 760 independent scientific citations in journals including Clinical Proteomics, Scientific Reports, Frontiers in Cell and Developmental Biology, Frontiers in Pharmacology, European Journal of Pharmaceutical Sciences, and International Journal of Molecular Sciences.
Shikha Sharma, PhD
Dr. Shikha Sharma holds a PhD in Biochemistry and leads scientific manuscript development, pharmacological mechanism-of-action reviews, and PRISMA 2020 evidence synthesis workflows at Science Habitat.
Dr. Sharma has co-authored extensively in high-impact peer-reviewed journals, including senior translational reviews and experimental arthritis studies in the European Journal of Pharmaceutical Sciences (2020 coumarin therapeutics review, 235+ citations; 2017 suramin oxidative-stress study), Scientific Reports (2024 human TNF-α peptide inhibitor study), Frontiers in Cell and Developmental Biology (2022 complement pathway proteomics), and Food and Chemical Toxicology.